. 2016 Aug 31;7(39):63960–63967. doi: 10.18632/oncotarget.11741

Table 2. Results of meta-analysis for the association between LSP1 rs1817198 T > C polymorphism and breast cancer risk.

Variables	N (cases/controls)	Homozygous			Heterozygous			Recessive			Dominant			Allele
		CC vs. TT			TC vs. TT			CC vs. (TC + TT)			(TC +CC) vs. TT			C vs. T
		OR (95% CI)	P^het	I² (%)	OR (95% CI)	P^het	I² (%)	OR (95% CI)	P^het	I² (%)	OR (95% CI)	P^het	I² (%)	OR (95% CI)	P^het	I² (%)
All	12(50,525/54302)	1.12 (1.02-1.24)	0.032	49.3	1.12 (0.90-1.39)	<0.001	97.6	1.07 (0.91-1.25)	<0.001	82.1	1.13 (0.94-1.36)	<0.001	97.1	1.09 (1.00-1.19)	<0.001	91.6
Ethnicity
Caucasian	6(11470/10331)	1.21 (1.10-1.32)	0.408	1.4	1.07 (1.01-1.13)	0.812	0.0	1.16 (1.07-1.27)	0.436	0.0	1.10 (1.04-1.16)	0.686	0.0	1.09 (1.05-1.13)	0.475	0.0
Asian	3(7624/5743)	1.17 (0.70-1.95)	0.563	0.0	1.07 (0.90-1.26)	0.324	0.0	1.14 (0.69-1.89)	0.606	0.0	1.07 (0.89-1.28)	0.277	15.4	1.09 (1.01-1.17)	0.515	0.0
African	1(742/658)	0.45 (0.22-0.92)	-	-	1.16 (0.92-1.47)	-	-	0.43 (0.22-0.88)	-	-	1.08 (0.86-1.35)	-	-	0.98 (0.81-1.20)	-	-
Mixed	2(30689/37570)	1.05 (0.94-1.17)	0.082	67.0	1.29 (0.70-2.41)	<0.001	99.7	0.90 (0.72-1.13)	<0.001	93.1	1.26 (0.73-2.17)	<0.001	99.6	1.12 (0,85-1.46)	<0.001	99.1
Source of control
Nested	3(38500/44177)	1.08 (0.99-1.18)	0.076	61.2	1.22 (0.79-1.88)	<0.001	99.5	0.97 (0.79-1.19)	<0.001	93.8	1.20 (0.83-1.74)	<0.001	99.4	1.10 (0.93-1.31)	<0.001	98.3
PB	7(10406/8365)	1.19 (0.88-1.63)	0.036	57.9	1.06 (0.97-1.17)	0.763	0.0	1.16 (0.86-1.56)	0.040	57.1	1.09 (0.99-1.19)	0.644	0.0	1.09 (1.03-1.15)	0.429	0.0
HB	2(1619/1760)	1.13 (0.81-1.56)	0.651	0.0	1.07 (0.91-1.25)	0.332	0.0	1.12 (0.82-1.54)	0.756	0.0	1.08 (0.92-1.26)	0.345	0.0	1.07 (0.94-1.22)	0.375	0.0

PB, population based; HB, hospital based.